This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Diagnosis  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Data From the Heart and Soul Study

David C. M. Corteville, MD; Kirsten Bibbins-Domingo, PhD, MD; Alan H. B. Wu, PhD; Sadia Ali, MD, MPH; Nelson B. Schiller, MD; Mary A. Whooley, MD

Arch Intern Med. 2007;167(5):483-489.

Background  N-terminal pro–B-type natriuretic peptide (NT-proBNP) testing is useful for diagnosing acute decompensated heart failure. Whether NT-proBNP can be used to detect ventricular dysfunction in patients with stable coronary heart disease (CHD) and no history of heart failure is unknown.

Methods  We measured NT-proBNP levels and performed transthoracic echocardiography in 815 participants from the Heart and Soul Study, who had stable CHD and no history of heart failure. We hypothesized that NT-proBNP concentrations lower than 100 pg/mL would rule out ventricular dysfunction and concentrations higher than 500 pg/mL would identify ventricular dysfunction. We calculated sensitivities, specificities, likelihood ratios, and areas under the receiver operating characteristic curves for NT-proBNP as a case-finding instrument for systolic and diastolic dysfunction.

Results  Of the 815 participants with no history of heart failure, 68 (8%) had systolic dysfunction defined as a left ventricular ejection fraction of 50% or lower. Of the 730 participants for whom the presence or absence of diastolic dysfunction could be determined, 78 (11%) had diastolic dysfunction defined as a pseudonormal or restrictive filling pattern. The overall area under the receiver operating characteristic curve for detecting systolic or diastolic dysfunction was 0.78 (95% confidence interval, 0.74-0.82). Likelihood ratios were 0.28 for NT-proBNP concentrations lower than 100 pg/mL, 0.95 for concentrations between 100 and 500 pg/mL, and 4.1 for concentrations higher than 500 pg/mL. A test result lower than 100 pg/mL reduced the probability of ventricular dysfunction from a pretest probability of 18% to a posttest probability of 6%. A test result higher than 500 pg/mL increased the probability of ventricular dysfunction from a pretest probability of 18% to a posttest probability of 47%. A test result between 100 and 500 pg/mL did not change the probability of ventricular dysfunction.

Conclusion  In patients with stable CHD and no history of heart failure, NT-proBNP levels lower than 100 pg/mL effectively rule out ventricular dysfunction, with a negative likelihood ratio of 0.28.

Author Affiliations: Departments of Medicine (Drs Corteville, Bibbins-Domingo, Schiller, and Whooley), Epidemiology and Biostatistics (Drs Bibbins-Domingo and Whooley), and Laboratory Medicine (Dr Wu), University of California, San Francisco; San Francisco General Hospital (Drs Bibbins-Domingo and Wu); and Department of Veterans Affairs Medical Center, San Francisco (Drs Ali, Schiller, and Whooley).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
Troughton and Richards
J Am Coll Cardiol Img 2009;2:216-225.
ABSTRACT | FULL TEXT  

Evidently...
Lehman
Evid. Based Med. 2007;12:103-103.
FULL TEXT